JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2004; 43:295-301, doi:10.1016/j.jacc.2003.09.026
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandrashekhar, Y.
Right arrow Articles by Anand, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chandrashekhar, Y.
Right arrow Articles by Anand, I.

BASIC SCIENCE

Long-Term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction

Y. Chandrashekhar, MD*,*, Soma Sen, MD*, Ruth Anway, BA*, Allan Shuros, BS* and Inder Anand, FRCP, DPhil(Oxon), FACC*

* Division of Cardiology, VA Medical Center and University of Minnesota, Minneapolis, Minnesota, USA

Manuscript received June 19, 2003; revised manuscript received September 15, 2003, accepted September 15, 2003.

* Reprint requests and correspondence: Dr. Y. Chandrashekhar, Associate Professor of Medicine, University of Minnesota, Division of Cardiology IIIc, VAMC, 1 Veterans Drive, Minneapolis, Minnesota 55417, USA.
shekh003{at}tc.umn.edu

OBJECTIVES: This study was designed to evaluate whether in vivo caspase inhibition can prevent myocardial contractile protein degradation, improve myocardial function, and attenuate ventricular remodeling.

BACKGROUND: Apoptosis is thought to play an important role in the development and progression of heart failure (HF) after a myocardial infarction (MI). However, it is not known whether inhibiting apoptosis can attenuate left ventricular (LV) remodeling and minimize systolic dysfunction.

METHODS: A 28-day infusion of caspase inhibitor (n = 12) or vehicle (n = 9) was administered to rats immediately after an anterior MI. In addition, five sham-operated rats given the caspase inhibitor were compared with 17 untreated sham-operated animals to study effects in non-MI rats. Left ventricular function, remodeling parameters, and hemodynamics were studied four weeks later. Myocardial caspase 3 activation and troponin-I contractile protein cleavage were studied in the non-infarct, remote LV myocardium using Western blots. Apoptosis was assessed using immunohistochemistry for activated caspase-positive cells as well as the TUNEL method. Collagen volume was estimated using morphometry.

RESULTS: Caspase inhibition reduced myocardial caspase 3 activation. This was accompanied by less cleavage of troponin-I, an important component of the cardiac contractile apparatus, and fewer apoptotic cardiomyocytes. Furthermore, caspase inhibition reduced LV-weight-to-body-weight ratio, decreased myocardial interstitial collagen deposition, attenuated LV remodeling, and better preserved LV systolic function after MI.

CONCLUSIONS: Caspase inhibition, started soon after MI and continued for four weeks, preserves myocardial contractile proteins, reduces systolic dysfunction, and attenuates ventricular remodeling. These findings may have important therapeutic implications in post-MI HF.

Abbreviations and Acronyms
  ANOVA = analysis of variance
  DMSO = dimethyl sulfoxide
  HF = heart failure
  LV = left ventricle/ventricular
  MI = myocardial infarction




This article has been cited by other articles:


Home page
 J Am Coll Cardiol ImgHome page
J. Narula and V. Dilsizian
From Better Understood Pathogenesis to Superior Molecular Imaging, and Back...
J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 406 - 409.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
E. D. Abel, S. E. Litwin, and G. Sweeney
Cardiac Remodeling in Obesity
Physiol Rev, April 1, 2008; 88(2): 389 - 419.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. M. Eggers, B. Lagerqvist, P. Venge, L. Wallentin, and B. Lindahl
Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality
Circulation, October 23, 2007; 116(17): 1907 - 1914.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. C. Shuros, R. W. Salo, V. G. Florea, J. Pastore, M. A. Kuskowski, Y. Chandrashekhar, and I. S. Anand
Ventricular Preexcitation Modulates Strain and Attenuates Cardiac Remodeling in a Swine Model of Myocardial Infarction
Circulation, September 4, 2007; 116(10): 1162 - 1169.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Merkle, S. Frantz, M. P. Schon, J. Bauersachs, M. Buitrago, R. J.A. Frost, E. M. Schmitteckert, M. J. Lohse, and S. Engelhardt
A Role for Caspase-1 in Heart Failure
Circ. Res., March 16, 2007; 100(5): 645 - 653.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
D. Hilfiker-Kleiner, U. Landmesser, and H. Drexler
Molecular Mechanisms in Heart Failure: Focus on Cardiac Hypertrophy, Inflammation, Angiogenesis, and Apoptosis
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A56 - A66.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
S. Roy, S. Khanna, D. E. Kuhn, C. Rink, W. T. Williams, J. L. Zweier, and C. K. Sen
Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix
Physiol Genomics, May 16, 2006; 25(3): 364 - 374.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Xydas, A. R. Kherani, J. S. Chang, S. Klotz, I. Hay, C. J. Mutrie, G. W. Moss, A. Gu, A. R. Schulman, D. Gao, et al.
beta2-Adrenergic Stimulation Attenuates Left Ventricular Remodeling, Decreases Apoptosis, and Improves Calcium Homeostasis in a Rodent Model of Ischemic Cardiomyopathy
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 553 - 561.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
T. A. Williams, A. Verhovez, A. Milan, F. Veglio, and P. Mulatero
Protective Effect of Spironolactone on Endothelial Cell Apoptosis
Endocrinology, May 1, 2006; 147(5): 2496 - 2505.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
I. S. Douglas, F. D. del Valle, R. A. Winn, and N. F. Voelkel
beta-Catenin in the Fibroproliferative Response to Acute Lung Injury
Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 274 - 285.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
L Galiuto, M Lotrionte, F Crea, A Anselmi, G G L Biondi-Zoccai, F De Giorgio, A Baldi, F Baldi, G Possati, M Gaudino, et al.
Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study
Heart, February 1, 2006; 92(2): 208 - 212.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Arredondo, A. I. Chernyavsky, A. Karaouni, and S. A. Grando
Novel Mechanisms of Target Cell Death and Survival and of Therapeutic Action of IVIg in Pemphigus
Am. J. Pathol., December 1, 2005; 167(6): 1531 - 1544.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Abbate, R. Bussani, G. G.L. Biondi-Zoccai, D. Santini, A. Petrolini, F. D. Giorgio, F. Vasaturo, S. Scarpa, A. Severino, G. Liuzzo, et al.
Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium
Eur. Heart J., October 1, 2005; 26(19): 2039 - 2045.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
V. P.M. van Empel, A. T.A. Bertrand, L. Hofstra, H. J. Crijns, P. A. Doevendans, and L. J. De Windt
Myocyte apoptosis in heart failure
Cardiovasc Res, July 1, 2005; 67(1): 21 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
R. Gottlieb
ICE-ing the Heart
Circ. Res., May 27, 2005; 96(10): 1036 - 1038.
[Full Text] [PDF]

Home page
 Nutr Clin PractHome page
B. Schreiber
Levocarnitine and Dialysis: A Review
Nutr Clin Pract, April 1, 2005; 20(2): 218 - 243.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Narula, J. Narula, P. J. Zhang, N. Haider, P. N. Raghunath, R. Brittin, J. H. Gorman III, R. C. Gorman, and J. E. Tomaszewski
Is the Myofibrillarlytic Myocyte a Forme Fruste Apoptotic Myocyte?
Ann. Thorac. Surg., April 1, 2005; 79(4): 1333 - 1337.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. M. Dallabrida, N. Ismail, J. R. Oberle, B. E. Himes, and M. A. Rupnick
Angiopoietin-1 Promotes Cardiac and Skeletal Myocyte Survival Through Integrins
Circ. Res., March 4, 2005; 96(4): e8 - e24.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C.-Y. Xiao, M. Chen, Z. Zsengeller, H. Li, L. Kiss, M. Kollai, and C. Szabo
Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 891 - 898.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al.
Highlights of the year in JACC 2004
J. Am. Coll. Cardiol., January 4, 2005; 45(1): 137 - 153.
[Full Text] [PDF]


HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.